Cross Shawn 4
4 · Pacira BioSciences, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Cross Shawn
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-10$22.09/sh−12,060$266,405→ 56,250 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.